Details for New Drug Application (NDA): 020710
✉ Email this page to a colleague
The generic ingredient in PAXIL is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.
Summary for 020710
Tradename: | PAXIL |
Applicant: | Apotex |
Ingredient: | paroxetine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 020710
Mechanism of Action | Serotonin Uptake Inhibitors |
Suppliers and Packaging for NDA: 020710
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PAXIL | paroxetine hydrochloride | SUSPENSION;ORAL | 020710 | NDA | Apotex Corp | 60505-0402 | 60505-0402-5 | 250 mL in 1 BOTTLE (60505-0402-5) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | EQ 10MG BASE/5ML | ||||
Approval Date: | Jun 25, 1997 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020710
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apotex | PAXIL | paroxetine hydrochloride | SUSPENSION;ORAL | 020710-001 | Jun 25, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Apotex | PAXIL | paroxetine hydrochloride | SUSPENSION;ORAL | 020710-001 | Jun 25, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Apotex | PAXIL | paroxetine hydrochloride | SUSPENSION;ORAL | 020710-001 | Jun 25, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Apotex | PAXIL | paroxetine hydrochloride | SUSPENSION;ORAL | 020710-001 | Jun 25, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription